Mesa, AZ — October 6, 2025 — Leads & Copy — Medical Care Technologies Inc. (OTC Pink:MDCE) will benchmark its upcoming AI diagnostic model against the HAM10000 public dermatology dataset.
The goal is to validate its image recognition architecture for detecting various skin lesion types. The benchmarking process will evaluate model precision, sensitivity, and specificity relative to peer-reviewed standards.
The HAM10000 data will be used under its research license as part of MDCE’s ongoing proof-of-concept development.
CEO Marshall Perkins III said the company is aligning its performance metrics with globally recognized academic standards. He added that this proactive benchmarking approach underscores their focus on building credible, evidence-backed AI systems for healthcare.
Investor Relations can be contacted at info@infiniteauctions.com.
Source: Medical Care Technologies Inc.
